HONG KONG, Oct 6 (SCMP): Zhang Yuntao, a senior executive of a pharmaceutical company which is developing two Covid-19 vaccines, seems a very popular man even among strangers. When attending industry seminars, people vie to take photos with him, add him on WeChat and ask if they or their loved ones can have an injection.
The vaccines developed by Zhang’s company, China National Biotec Group (CNBG), are still being tested for safety and efficacy in human trials, but have been taken by about 350,000 people in China under an emergency use scheme. Contrary to the caution shown in the West over use of vaccines before their regulatory approval, it is much sought after.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
